目录
- Robotic lobectomy - the future of minimally invasive lobectomy?
- Evolving thoracic surgery: from open surgery to single port thoracoscopic surgery and future robotic
- Improving cancer therapy by combining cell biological,physical,and molecular targeting strategies
- Report of incidence and mortality in China cancer registries,2009
- Significance of ipsilateral breast tumor recurrence after breast conserving treatment: role of surgical removal
- Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma
- Diagnosis of breast cancer by tissue analysis
- Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients
- Current diagnostic approach to patients with adnexal masses:which tools are relevant in routine praxis?
- Imatinib as preoperative therapy in Chinese patients with recurrent or metastatic GISTs
- Primarily screening and analyzing ESTs differentially expressed in rats’ primary liver cancer
- LGR5 is a promising biomarker for patients with stage I and II gastric cancer
- Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
- Prognostic value of interim18F-FDG PET/CT in diffuse large B-cell lymphoma
- TGF-β1 alters microRNA profile in human gastric cancer cells
- Clinicopathological analysis of metaplastic meningioma: report of 15 cases in Huashan Hospital
- A case of rapid growing colonic NK/T cell lymphoma complicated by Crohn’s disease
- Nonintubated thoracoscopic lobectomy plus lymph node dissection following segmentectomy for central type pulmonary masses